Doping in Sport: Misuse, Analytical Tests, And Legal Aspects (Editorial) Doping in Sport: Misuse, Analytical Tests, And Legal Aspects (Editorial)

Doping in Sport: Misuse, Analytical Tests, And Legal Aspects (Editorial‪)‬

Clinical Chemistry 1997, July, 43, 7

    • 2,99 €
    • 2,99 €

Beschreibung des Verlags

As part of the International Congress of Clinical Chemistry, a symposium, Doping in Sport: Misuse, Analytical Tests, and Legal Aspects, was held, a week before the start of the Olympic Games at Atlanta, bringing together a number of international experts concerned with various aspects of controlling drug abuse in sport. The presentations focused particularly on anabolic-androgenic steroids (AAS), these analytes still comprising the greatest number of positive findings in samples tested by International Olympic Committee (IOC)-accredited sports drug-testing laboratories. Although various aspects of AAS use and detection have been reported on in the last decade, the proceedings of this symposium, published in this issue of Clinical Chemistry, bring together health, social, endocrine, and analytical perspectives in a widely read peer-reviewed journal. Those who think that the harmful effects of AAS administration are relatively benign and perhaps should not be banned by the IOC may find particularly sobering the article by Franke and Berendonk [1], which describes the health and social consequences of the clandestine state-sponsored program of administration of AAS in the former East Germany. This article should be extremely useful for educational purposes and, we hope, will encourage some present users to abandon the practice. The mechanism of action of AAS is still not well understood, and the article by Wu [2] is a useful update. Catlin et al. [3] discuss the pertinent issues of detecting AAS administration, in particular of testosterone (T), which is commonly abused. Stenman et al. [4] give a clinical chemistry perspective on the problems of detecting human chorionic gonadotropin (hCG) by immunoassay, the protein hormone that may be used by competitors to stimulate testicular production of T. Bowers [5] discusses analytical advances to detect performance-enhancing compounds, particularly with reference to xenobiotic AAS and peptide hormones, such as hCG.

GENRE
Wissenschaft und Natur
ERSCHIENEN
1997
1. Juli
SPRACHE
EN
Englisch
UMFANG
13
Seiten
VERLAG
American Association for Clinical Chemistry, Inc.
GRÖSSE
170,8
 kB

Mehr ähnliche Bücher

Doping, Performance-Enhancing Drugs, and Hormones in Sport (Enhanced Edition) Doping, Performance-Enhancing Drugs, and Hormones in Sport (Enhanced Edition)
2017
Point/Counterpoint: The Case Against Bioidentical Hormones (Drug Overview) Point/Counterpoint: The Case Against Bioidentical Hormones (Drug Overview)
2008
Contemporary Practice in Clinical Chemistry (Enhanced Edition) Contemporary Practice in Clinical Chemistry (Enhanced Edition)
2020
Maximize Your Vitality & Potency for Men Over 40 Maximize Your Vitality & Potency for Men Over 40
1999
Principles of Pharmacogenetics and Pharmacogenomics Principles of Pharmacogenetics and Pharmacogenomics
2012
Molecular Mechanisms of Nutritional Interventions and Supplements for the Management of Sexual Dysfunction and Benign Prostatic Hyperplasia (Enhanced Edition) Molecular Mechanisms of Nutritional Interventions and Supplements for the Management of Sexual Dysfunction and Benign Prostatic Hyperplasia (Enhanced Edition)
2021

Mehr Bücher von Clinical Chemistry

Highly Sensitive Immunoprecipitation Method for Extracting and Concentrating Low-Abundance Proteins from Human Serum (Technical Briefs) Highly Sensitive Immunoprecipitation Method for Extracting and Concentrating Low-Abundance Proteins from Human Serum (Technical Briefs)
2005
Longitudinal Concentrations of Vitamin [B.Sub.12] and Vitamin [B.Sub.12]-Binding Proteins During Uncomplicated Pregnancy (General Clinical Chemistry) (Clinical Report) Longitudinal Concentrations of Vitamin [B.Sub.12] and Vitamin [B.Sub.12]-Binding Proteins During Uncomplicated Pregnancy (General Clinical Chemistry) (Clinical Report)
2002
Multicenter Characterization and Validation of the Intron-8 Poly(T) Tract (IVS8-T) Status in 25 Coriell Cell Repository Cystic Fibrosis Reference Cell Lines for Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene Mutation Assays (Technical Briefs) Multicenter Characterization and Validation of the Intron-8 Poly(T) Tract (IVS8-T) Status in 25 Coriell Cell Repository Cystic Fibrosis Reference Cell Lines for Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene Mutation Assays (Technical Briefs)
2004
Immunoassay Standardization: Is It Possible, Who Is Responsible, Who Is Capable?(Opinion) (Clinical Report) Immunoassay Standardization: Is It Possible, Who Is Responsible, Who Is Capable?(Opinion) (Clinical Report)
2001
A Conversation with Elizabeth Blackburn (Interview) A Conversation with Elizabeth Blackburn (Interview)
2009
The Evolution of Immunoassay As Seen Through the Journal Clinical Chemistry (Aacc 50th Years Anniversary Retrospective) The Evolution of Immunoassay As Seen Through the Journal Clinical Chemistry (Aacc 50th Years Anniversary Retrospective)
1998